Taking a comprehensive approach to executing our “U.S.-first” #strategy is discussed by Victor Bulto. This focus includes early research, drug profile selection, clinical development, commercialization and patient services. @FiercePharma #Investors #JPM23 t.co/cDLafgDIEM